Low-dose taurine upregulates taurine transporter expression in acute myocardial ischemia

Zhang,Yue; Yang,Lin; Yang,Yu-Jie; Liu,Xiao-Yu; Jia,Jian-Guo; Qian,Ju-Ying; Wang,Ke-Qiang; Zuo,Ji; Ge,Jun-Bo

doi:10.3892/ijmm.2013.1264

Low-dose taurine upregulates taurine transporter expression in acute myocardial ischemia

Authors:
- Yue Zhang
- Lin Yang
- Yu-Jie Yang
- Xiao-Yu Liu
- Jian-Guo Jia
- Ju-Ying Qian
- Ke-Qiang Wang
- Ji Zuo
- Jun-Bo Ge
View Affiliations

Affiliations: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, P.R. China, Eye and ENT Hospital, Fudan University, Shanghai, P.R. China, Department of Cellular and Genetic Medicine, Shanghai Medical College, Fudan University, Shanghai, P.R. China
Published online on: February 1, 2013 https://doi.org/10.3892/ijmm.2013.1264
Pages: 817-824

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Taurine exerts a protective effect on cardiomyocytes. The aim of this study was to determine whether the protective effect of taurine is associated with the upregulation of taurine transporter (TAUT) expression in acute myocardial ischemia (AMI). To this end, we investigated TAUT expression in cultured cardiomyocytes exposed to hypoxia as well as in rats with AMI treated with or not with taurine. The morphology of cardiac tissues, the apoptosis of cardiomyocytes and cardiac function were examined. In addition, the taurine content and the expression of TAUT were measured. Our data demonstrated that taurine reversed the apoptosis induced by hypoxia and AMI, thereby, effectively protecting the myocardium. Taurine content and TAUT expression levels were significantly decreased when cardiomyocytes and cardiac tissues were subjected to hypoxic or ischemic stress, while the expression of cysteine sulﬁnate decarboxylase was unchanged. Moreover, treatment with taurine (100 mg/kg/day) significantly upregulated TAUT expression and elevated the taurine content in ischemic myocardial tissues. In vitro, the low-dose (40 mM) but not the high-dose (120 mM) administration of taurine significantly induced TAUT expression and elevated the intracellular taurine content in hypoxic cardiomyocytes. In conclusion, our data demonstrate that taurine exerts a protective effect on the ischemic myocardium. Low-dose but not high-dose taurine treatment upregulated TAUT expression and increased the intracellular taurine content in cardiomyocytes subjected to hypoxia as well as in AMI tissues.

View Figures

View References

1	Huxtable RJ: Physiological actions of taurine. Physiol Rev. 72:101–163. 1992.
2	Chapman RA, Suleiman MS and Earm YE: Taurine and the heart. Cardiovasc Res. 27:358–363. 1993. View Article : Google Scholar : PubMed/NCBI
3	Azuma J, Hasegawa H, Sawamura A, et al: Therapy of congestive heart failure with orally administered taurine. Clin Ther. 5:398–408. 1983.PubMed/NCBI
4	Azuma J, Sawamura A, Awata N, et al: Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol. 8:276–282. 1985. View Article : Google Scholar : PubMed/NCBI
5	Takihara K, Azuma J, Awata N, et al: Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J. 112:1278–1284. 1986. View Article : Google Scholar : PubMed/NCBI
6	Oudit GY, Trivieri MG, Khaper N, et al: Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation. 109:1877–1885. 2004. View Article : Google Scholar
7	Schaffer S, Takahashi K and Azuma J: Role of osmoregulation in the actions of taurine. Amino Acids. 19:527–546. 2000. View Article : Google Scholar : PubMed/NCBI
8	Satoh H and Sperelakis N: Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol. 30:451–463. 1998. View Article : Google Scholar : PubMed/NCBI
9	Takatani T, Takahashi K, Uozumi Y, et al: Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway. Biochem Biophys Res Commun. 316:484–489. 2004. View Article : Google Scholar : PubMed/NCBI
10	Takatani T, Takahashi K, Uozumi Y, et al: Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. Am J Physiol Cell Physiol. 287:C949–C953. 2004. View Article : Google Scholar : PubMed/NCBI
11	Bitoun M, Levillain O and Tappaz M: Gene expression of the taurine transporter and taurine biosynthetic enzymes in rat kidney after antidiuresis and salt loading. Pflugers Arch. 442:87–95. 2001. View Article : Google Scholar : PubMed/NCBI
12	Han X, Budreau AM and Chesney RW: Adaptive regulation of MDCK cell taurine transporter (pNCT) mRNA: transcription of pNCT gene is regulated by external taurine concentration. Biochim Biophys Acta. 1351:296–304. 1997. View Article : Google Scholar : PubMed/NCBI
13	Takahashi K, Ohyabu Y, Takahashi K, et al: Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. J Cardiovasc Pharmacol. 41:726–733. 2003. View Article : Google Scholar : PubMed/NCBI
14	Oriyanhan W, Yamazaki K, Miwa S, Takaba K, Ikeda T and Komeda M: Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels. 20:278–285. 2005. View Article : Google Scholar
15	Shi YR, Gao L, Wang SH, et al: Inhibition of taurine transport by high concentration of glucose in cultured rat cardiomyocytes. Metabolism. 52:827–833. 2003. View Article : Google Scholar : PubMed/NCBI
16	Reymond I, Bitoun M, Levillain O and Tappaz M: Regional expression and histological localization of cysteine sulfinate decarboxylase mRNA in the rat kidney. J Histochem Cytochem. 48:1461–1468. 2000. View Article : Google Scholar : PubMed/NCBI
17	Beetsch JW and Olson JE: Taurine synthesis and cysteine metabolism in cultured rat astrocytes: effects of hyperosmotic exposure. Am J Physiol. 274:C866–C874. 1998.PubMed/NCBI
18	World Health Organization. Global Burden of Disease. WHO Press; Geneva: 2008
19	Mozaffarian D and Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 296:1885–1899. 2006. View Article : Google Scholar : PubMed/NCBI
20	Nittynen L, Nurminen ML, Korpela R and Vapaatalo H: Role of arginine, taurine and homocysteine in cardiovascular diseases. Ann Med. 31:318–326. 1999. View Article : Google Scholar : PubMed/NCBI
21	Ghosh J, Das J, Manna P and Sil PC: Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol. 240:73–87. 2009. View Article : Google Scholar
22	Li Y, Arnold JM, Pampillo M, Babwah AV and Peng T: Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation. Free Radic Biol Med. 46:51–61. 2009. View Article : Google Scholar : PubMed/NCBI
23	Bitoun M and Tappaz M: Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions. Glia. 32:165–176. 2000. View Article : Google Scholar : PubMed/NCBI
24	Ramamoorthy S, Leibach FH, Mahesh VB, et al: Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. Biochem J. 300:893–900. 1994.PubMed/NCBI
25	Tappaz ML: Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem Res. 29:83–96. 2004. View Article : Google Scholar : PubMed/NCBI
26	Shi YR, Qi YF, Bu DF, et al: Dysfunction of myocardial and vascular taurine transport in spontaneously hypertensive rats. Sheng Li Xue Bao. 54:359–364. 2002.PubMed/NCBI
27	Melo TM, Nehlig A and Sonnewald U: Metabolism is normal in astrocytes in chronically epileptic rats: a (13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J Cereb Blood Flow Metab. 25:1254–1264. 2005. View Article : Google Scholar : PubMed/NCBI
28	Zeng K, Xu H, Mi M, et al: Effects of taurine on glial cells apoptosis and taurine transporter expression in retina under diabetic conditions. Neurochem Res. 35:1566–1574. 2010. View Article : Google Scholar : PubMed/NCBI
29	Satsu H, Terasawa E, Hosokawa Y and Shimizu M: Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells. Biochem J. 375:441–447. 2003. View Article : Google Scholar : PubMed/NCBI
30	Chang L, Zhao J, Xu J, Jiang W, Tang CS and Qi YF: Effects of taurine and homocysteine on calcium homeostasis and hydrogen peroxide and superoxide anions in rat myocardial mitochondria. Clin Exp Pharmacol Physiol. 31:237–243. 2004. View Article : Google Scholar : PubMed/NCBI
31	Sahin MA, Yucel O, Guler A, et al: Is there any cardioprotective role of Taurine during cold ischemic period following global myocardial ischemia? J Cardiothorac Surg. 6:312011. View Article : Google Scholar : PubMed/NCBI